|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.40 DKK | +3.09% |
|
+0.05% | -4.08% |
| 05-18 | Lundbeck's Asedebart Secures Orphan Drug Designation in Japan | MT |
| 05-18 | Lundbeck granted Orphan Drug Designation in Japan for asedebart | FW |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 3.87B | 12.96% | 21.42% | 20.93% | 6.13% | 1.04x | ||
| 403B | 1.18% | 1.6% | - | 6.16% | 0.37x | ||
| 223B | 0.7% | 1.25% | - | 4.06% | 1.5x | ||
| 3.93B | 8.83% | 13.9% | 62.88% | 22.61% | 0.91x | ||
| 40.54B | 2.02% | 3.51% | 7.74% | 2.52% | 1.57x | ||
| 6.24B | 7.83% | 9.42% | 14.28% | 10.47% | -0.59x | ||
| 82.23B | 1.24% | 3.07% | 8.79% | 1.83% | 0.91x | ||
| 5.22B | 4.38% | 5.68% | 11.95% | 5.69% | 3.22x | ||
| 24.52B | 1.1% | 1.51% | 6.6% | 3.6% | -3.53x | ||
| 23.07B | 1.4% | 2.05% | 8.29% | 2.5% | -1.13x | ||
| 7.5B | 3.81% | 5% | 11.26% | 5.3% | - | ||
| 8.91B | 1.75% | 3.79% | 9.88% | 3.65% | 1.42x | ||
| 16.03B | 1.44% | 1.55% | 8.4% | 3.32% | -2.88x | ||
| 10.5B | 1.55% | 2.06% | 6.26% | 2.3% | -2.32x | ||
| 10.14B | 1.31% | 1.25% | 7.8% | 2.77% | -2.61x | ||
| 1.07B | 6.32% | 9.81% | 20.77% | - | - | ||
| 4B | -0.22% | 1.2% | -1.25% | -0.44% | - | ||
| Average | 51.4B | 3.39% | 5.18% | 13.64% | 5.15% | -0.15x | |
| Weighted average by Cap. | 224B | 2.65% | 4.02% | 26.17% | 7.06% | 0.63x |
- Stock Market
- Equities
- HLUN B Stock
- Sector H. Lundbeck A/S
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















